Clinical trial
XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
NCT02506985 is registered in ClinicalTrials.gov with Susan Smyth as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
- Lead sponsor
- Susan Smyth
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2015
- Completion date
- June 29, 2016
- Enrollment
- 10 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.